Literature DB >> 17017823

Association study of the 5-HTTLPR polymorphism and depression in 75-Year-Old nondemented subjects from the Vienna Transdanube Aging (VITA) study.

Edna Grünblatt1, Christiane Löffler, Sonja Zehetmayer, Susanne Jungwirth, Karl-Heinz Tragl, Peter Riederer, Peter Fischer.   

Abstract

BACKGROUND: The site of effect for the selective serotonin reuptake inhibitors (SSRIs) is the serotonin transporter (5-HTT), which is extensively investigated for its involvement in depressive symptoms. The 5-HTT gene exhibits a 5'-promoter-based length polymorphism (5-HTTLPR) that affects the transcription efficiency and activity, known as short (S) and long (L) alleles. We studied the association of this polymorphism in old age and depression in the Vienna Transdanube Aging (VITA) study, excluding subjects with dementia.
METHOD: We used retrospective data from the baseline of the VITA study, which is a cohort study of all inhabitants of a geographical area aged 75 years (N = 544). Depression was diagnosed and classified strictly according to the DSM-IV. To eliminate dementia effects, we excluded subjects with a Clinical Dementia Rating higher than or equal to 1 and/or a Mini-Mental State Examination score lower than 24. Genotyping for the 5-HTTLPR L/S allele was conducted using polymerase chain reaction methodology.
RESULTS: We found significantly higher SS genotype frequency in all subjects with past/ present depression compared to controls (trend test, p = .01). The SS genotype frequency was especially high in subjects with onset of depression before age 65. No correlations were found between genotypes/S allele carriers and actual Hamilton Rating Scale for Depression, Short-Geriatric Depression Scale, and anxiety scale scores.
CONCLUSIONS: These observations of higher frequency of the 5-HTTLPR S allele in subjects with past/present depression fit with previous findings and point to the important role of 5-HTT in depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017823     DOI: 10.4088/jcp.v67n0907

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

2.  Population-based study of first onset and chronicity in major depressive disorder.

Authors:  William W Eaton; Huibo Shao; Gerald Nestadt; Hochang Benjamin Lee; Ben Hochang Lee; O Joseph Bienvenu; Peter Zandi
Journal:  Arch Gen Psychiatry       Date:  2008-05

3.  Genetic association of daytime sleepiness and depressive symptoms in elderly men.

Authors:  Christina N Lessov-Schlaggar; Donald L Bliwise; Ruth E Krasnow; Gary E Swan; Terry Reed
Journal:  Sleep       Date:  2008-08       Impact factor: 5.849

4.  Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort.

Authors:  Claus-Jürgen Scholz; Heike Weber; Susanne Jungwirth; Walter Danielczyk; Andreas Reif; Karl-Heinz Tragl; Peter Fischer; Peter Riederer; Jürgen Deckert; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

Review 5.  The Protective Role of Neurogenetic Components in Reducing Stress-Related Effects during Spaceflights: Evidence from the Age-Related Positive Memory Approach.

Authors:  Nicola Mammarella; Matteo Gatti; Irene Ceccato; Adolfo Di Crosta; Alberto Di Domenico; Rocco Palumbo
Journal:  Life (Basel)       Date:  2022-08-02

Review 6.  Disruption of the circadian timing systems: molecular mechanisms in mood disorders.

Authors:  Julien Mendlewicz
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.